COBRE-DIABETES
COBRE-DIABETES
批准号:
10395384
负责人:
MARIANA GERSCHENSON
金额:
$31.1万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-08-01 至 2023-07-31
关键词:
AffectAgeAmbulatory Care FacilitiesAmerican IndiansAnxietyAsiansAssessment toolBody mass indexCardiometabolic DiseaseCardiovascular DiseasesCause of DeathCenters of Research ExcellenceDiabetes MellitusDiagnostic Reagent KitsDietEnrollmentEpidemicEthnic groupFocus GroupsFutureGestational DiabetesGlucoseGlucose tolerance testGlycosylated HemoglobinGlycosylated hemoglobin AGoalsHigh PrevalenceHigh Risk WomanHourInterventionKnowledgeLifeLife StyleLinear RegressionsLiteratureMeasuresMedical centerNative HawaiianNon-Insulin-Dependent Diabetes MellitusOutpatientsPacific Island AmericansParticipantPhysical activityPittsburgh Sleep Quality IndexPopulationPopulation HeterogeneityPostpartum PeriodPostpartum WomenPregnancyPregnancy ComplicationsPregnant WomenPrevalencePrevention strategyPublic HealthRaceRecording of previous eventsReportingRiskRisk FactorsSeveritiesSleepSleep DeprivationSleeplessnessTimeUnited StatesWomanbasecardiometabolic riskcardiometabolismcardiovascular disorder riskcaregivingdiabetes riskethnic diversityethnic minority populationevidence basehealth disparityhigh riskhome testindexinginsightmortalitymulti-ethnicnovelphysical inactivityprogramsracial and ethnicracial diversityrecruitsleep quality
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT
Cardiovascular disease (CVD) is the leading cause of death in women in the U.S, and complications during
pregnancy, including gestational diabetes (GDM), are associated with risk of CVD and type 2 diabetes mellitus
(DM) later in life. Women with DM have increased risk of CVD, and women with a history of GDM have 7 times
higher risk for DM post-delivery compared with women who had a normoglycemic pregnancy. An increasingly
important risk factor for GDM and DM is sleep deficiency, and women appear to be more vulnerable to the
effects of sleep deficiency on cardiometabolic risk and mortality. Pregnancy and postpartum offer a window of
opportunity to mitigate DM1 risk in high risk women of diverse racial/ethnic background. Sleep deficiencies are
commonly reported during pregnancy and about 50% of women with history of GDM develop DM, however
little is known about sleep deficiency and glycemic status at postpartum. Furthermore, sleep deficiencies and
associated risk of diabetes and CVD unequally affect racial/ethnic minorities.
Our long-term goal is to identify and disseminate evidence-based, culturally sensitive interventions to
reduce sleep deficiencies in women during pregnancy and postpartum, and thus reduce the risk of type 2 DM.
The objectives of this study are to understand the association between sleep deficiencies and glycemic status
in women with a history of GDM. We propose a study with 200 women with history of GDM in the A Sweeter
Choice (ASC) program, an established outpatient diabetes program at Kapi`olani Medical Center, Honolulu,
Hawai`i, started in 1995 that has recruited over 10,000 multi-ethnic women with GDM and/or preexisting DM.
We will assess sleep deficiency - sleep duration, sleep quality, insomnia severity, and morning-evening sleep
choronotype using validated assessment tools.
Our first aim is to describe the underlying factors contributing to risk for sleep deficiency in a population
of postpartum women from diverse race/ethnic backgrounds with a prior history of GDM. We will conduct a
total of 4-8 focus groups with 5-10 participants in each focus group by recruiting women from the ASC program
at 6 – 12 months postpartum. Our goal is to gain a deeper understanding of the perspectives of women with a
prior pregnancy complicated by GDM on sleep deficiency during pregnancy and postpartum. Our second aim
is to examine the association of sleep deficiencies and glycemic status in a population of women from diverse
race/ethnic backgrounds with a history of GDM. Sleep deficiencies and HbA1c will be evaluated in 150 women
from the ASC program at 6 – 12 months postpartum. Sleep deficiencies will be assessed using the Pittsburgh
Sleep Quality Index (PSQI), insomnia severity index, and the morning-evening chronotype assessment, and
glycemic status using an HbA1c home test kit. The association between sleep deficiencies and glycemic status
will be estimated using linear regression of glycemic status on each measure of sleep deficiency and as a
composite sleep deficiency score, adjusted for confounders.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MARC at University of Hawaii at Manoa
-
批准号:10624858
-
项目类别:
-
资助金额:$45.95万
-
财政年份:2021
-
负责人:MARIANA GERSCHENSON
-
依托单位:
COBRE-DIABETES
-
批准号:10387025
-
项目类别:
-
资助金额:$21.85万
-
财政年份:2017
-
负责人:MARIANA GERSCHENSON
-
依托单位:
COBRE-DIABETES
-
批准号:10399857
-
项目类别:
-
资助金额:$23.18万
-
财政年份:2017
-
负责人:MARIANA GERSCHENSON
-
依托单位:
Administrative and Mentoring Core
-
批准号:10013266
-
项目类别:
-
资助金额:$72.66万
-
财政年份:2017
-
负责人:MARIANA GERSCHENSON
-
依托单位:
COBRE-DIABETES
-
批准号:9211064
-
项目类别:
-
资助金额:$230.03万
-
财政年份:2017
-
负责人:MARIANA GERSCHENSON
-
依托单位:
COBRE-DIABETES
-
批准号:10013264
-
项目类别:
-
资助金额:$215.68万
-
财政年份:2017
-
负责人:MARIANA GERSCHENSON
-
依托单位:
Administrative and Mentoring Core
-
批准号:10252771
-
项目类别:
-
资助金额:$67.93万
-
财政年份:2017
-
负责人:MARIANA GERSCHENSON
-
依托单位:
COBRE-DIABETES
-
批准号:10252770
-
项目类别:
-
资助金额:$212.34万
-
财政年份:2017
-
负责人:MARIANA GERSCHENSON
-
依托单位:
HAWAII AIDS CLINICAL RESEARCH PROGRAM/MEDICINE
-
批准号:8168067
-
项目类别:
-
资助金额:$32.36万
-
财政年份:2010
-
负责人:MARIANA GERSCHENSON
-
依托单位:
Mitochondrial Determinants of Metabolic Disease in HIV-Infected Children
-
批准号:8150961
-
项目类别:
-
资助金额:$50.92万
-
财政年份:2010
-
负责人:MARIANA GERSCHENSON
-
依托单位:
Mitochondrial Determinants of Metabolic Disease in HIV-Infected Children
-
批准号:8680049
-
项目类别:
-
资助金额:$45.26万
-
财政年份:2010
-
负责人:MARIANA GERSCHENSON
-
依托单位:
Mitochondrial Determinants of Metabolic Disease in HIV-Infected Children
-
批准号:8088909
-
项目类别:
-
资助金额:$57.16万
-
财政年份:2010
-
负责人:MARIANA GERSCHENSON
-
依托单位:
Mitochondrial Determinants of Metabolic Disease in HIV-Infected Children
-
批准号:8289335
-
项目类别:
-
资助金额:$48.64万
-
财政年份:2010
-
负责人:MARIANA GERSCHENSON
-
依托单位:
Mitochondrial Determinants of Metabolic Disease in HIV-Infected Children
-
批准号:8473920
-
项目类别:
-
资助金额:$44.48万
-
财政年份:2010
-
负责人:MARIANA GERSCHENSON
-
依托单位:
MITOCHODRIAL DYSFUNCTION IN OBESITY AND DIABETES IN BLOOD
-
批准号:7858531
-
项目类别:
-
资助金额:$18.64万
-
财政年份:2009
-
负责人:MARIANA GERSCHENSON
-
依托单位:
Global HIV Drug Therapies and Mitochondrial Complications and Mechanisms
-
批准号:7758370
-
项目类别:
-
资助金额:$64.7万
-
财政年份:2008
-
负责人:MARIANA GERSCHENSON
-
依托单位:
Global HIV Drug Therapies and Mitochondrial Complications and Mechanisms
-
批准号:8213520
-
项目类别:
-
资助金额:$61.34万
-
财政年份:2008
-
负责人:MARIANA GERSCHENSON
-
依托单位:
HAWAII AIDS CLINICAL RESEARCH PROGRAM/MEDICINE
-
批准号:7725232
-
项目类别:
-
资助金额:$17.45万
-
财政年份:2008
-
负责人:MARIANA GERSCHENSON
-
依托单位:
Global HIV Drug Therapies and Mitochondrial Complications and Mechanisms
-
批准号:8013497
-
项目类别:
-
资助金额:$62.12万
-
财政年份:2008
-
负责人:MARIANA GERSCHENSON
-
依托单位:
Global HIV Drug Therapies and Mitochondrial Complications and Mechanisms
-
批准号:7425133
-
项目类别:
-
资助金额:$66.28万
-
财政年份:2008
-
负责人:MARIANA GERSCHENSON
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: